Benzinga | Nov 10, 2021 07:56AM EST

Aadi Bioscience Q3 EPS $(9.17) Down From $(1.23) YoY

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(9.17) per share. This is a 645.53 percent decrease over losses of $(1.23) per share from the same period last year.